FATE
Fate Therapeutics, Inc. · Healthcare
Redmile Group, LLC bought $166K of Fate Therapeutics, Inc.
Director and 10% owner
Bought$166,024
$3.72Price
44,630Shares
What FATE did for a copier
- $1,000 copied at Fri, Dec 29 open, $4.09
- $1,562
- S&P 500, same days
- +3.7%
Measured over 30 trading days, to the Feb 13 close.
Redmile Group, LLC's record
10 other buys with 3 months of prices since 2016: on average −23.7% against the S&P 500, and 2 of 10 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Dec 26. Filed Thu, Dec 28, 9:30 PM ET, after the close. Returns use the Dec 29 open and the Feb 13 close. Not investment advice.